Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA)
Improvements in chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), and multiple myeloma (MM) treatment options have increased the 5-year survival rates for patients with these hematologic malignancies. In addition to cancer management, these patients may need help to manage multiple...
Main Authors: | Karen B. Farris, Tiffany Cadwallader, Joel Farley, Katie Gatwood, Emily Mackler, Justin Gatwood |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Exploratory Research in Clinical and Social Pharmacy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667276622000622 |
Similar Items
-
The Expanding Role of the Oncology Pharmacist
by: Lisa M. Holle, et al.
Published: (2020-07-01) -
Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations
by: Gennaro A. Paolella, et al.
Published: (2018-03-01) -
Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review
by: Oluwafemifola Oyedeji, et al.
Published: (2021-11-01) -
A pharmacist check of patients’ infection-related condition prior to drug preparation reduces anticancer drug wastage after mixing: a retrospective study
by: Hirotsugu Yamada, et al.
Published: (2023-01-01) -
Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic
by: Farah Raheem, et al.
Published: (2020-03-01)